Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Martin Dekker currently holds 17,666 shares of Bellerophon Therapeutics, Inc. (BLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Dekker has been a net neutral trader of BLPH stock. They have purchased $0 and sold $0 worth of shares.
Martin Dekker's most recent insider trade was on Dec 9, 2022, when they sold 7,834 shares at $0.93 per share.
Martin Dekker serves as Executive at Bellerophon Therapeutics, Inc. (BLPH). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Martin Dekker holds the position of Executive at Bellerophon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Martin Dekker has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Martin Dekker was on Jan 4, 2018, when they sold $60.5K worth of BLPH shares. This transaction involved 24,284 shares at $2.49 per share.
Martin Dekker currently owns 17,666 shares of Bellerophon Therapeutics, Inc. (BLPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Martin Dekker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martin Dekker has 10 Form 4 filings on record as an insider at Bellerophon Therapeutics, Inc..
Set alerts for Martin Dekker and 40,000+ other insiders.